Ginkgo Bioworks Holdings, Inc. (DNA)
7.41
-0.13
(-1.72%)
USD |
NYSE |
Aug 26, 09:47
Ginkgo Bioworks Holdings Enterprise Value : 556.80M for Aug. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 556.80M |
| August 24, 2026 | 510.66M |
| August 21, 2026 | 548.30M |
| August 20, 2026 | 521.58M |
| August 19, 2026 | 567.12M |
| August 18, 2026 | 495.48M |
| August 17, 2026 | 519.16M |
| August 14, 2026 | 511.26M |
| August 13, 2026 | 538.58M |
| August 12, 2026 | 536.76M |
| August 11, 2026 | 554.98M |
| August 10, 2026 | 563.47M |
| August 07, 2026 | 582.90M |
| August 06, 2026 | 615.08M |
| August 05, 2026 | 667.90M |
| August 04, 2026 | 667.90M |
| August 03, 2026 | 641.79M |
| July 31, 2026 | 590.19M |
| July 30, 2026 | 590.19M |
| July 29, 2026 | 561.65M |
| July 28, 2026 | 566.51M |
| July 27, 2026 | 551.33M |
| July 24, 2026 | 545.87M |
| July 23, 2026 | 580.47M |
| July 22, 2026 | 574.40M |
| Date | Value |
|---|---|
| July 21, 2026 | 578.05M |
| July 20, 2026 | 557.40M |
| July 17, 2026 | 579.26M |
| July 16, 2026 | 602.33M |
| July 15, 2026 | 645.43M |
| July 14, 2026 | 647.86M |
| July 13, 2026 | 648.47M |
| July 10, 2026 | 650.90M |
| July 09, 2026 | 689.75M |
| July 08, 2026 | 649.68M |
| July 07, 2026 | 666.08M |
| July 06, 2026 | 712.82M |
| July 02, 2026 | 730.43M |
| July 01, 2026 | 723.15M |
| June 30, 2026 | 700.68M |
| June 29, 2026 | 629.29M |
| June 26, 2026 | 631.63M |
| June 25, 2026 | 591.74M |
| June 24, 2026 | 601.13M |
| June 23, 2026 | 550.10M |
| June 22, 2026 | 560.65M |
| June 18, 2026 | 568.28M |
| June 17, 2026 | 531.91M |
| June 16, 2026 | 511.97M |
| June 15, 2026 | 513.14M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Sotera Health Co. | 7.479B |
| Caris Life Sciences, Inc. | 7.574B |
| BillionToOne, Inc. | 4.281B |
| Quest Diagnostics, Inc. | 33.04B |
| Labcorp Holdings, Inc. | 33.96B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -57.32M |
| Revenue (Quarterly) | 20.16M |
| Total Expenses (Quarterly) | 77.48M |
| EPS Diluted (Quarterly) | -1.147 |
| Gross Profit Margin (Quarterly) | 30.37% |
| Profit Margin (Quarterly) | -284.4% |
| Earnings Yield | -73.43% |
| Normalized Earnings Yield | -73.40 |